drospirenone has been researched along with Endometrioma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Suzukamo, Y; Takahashi, N; Yoshihara, K; Yoshino, O | 1 |
| Fujii, T; Harada, M; Hasegawa, A; Hirata, T; Hirota, Y; Izumi, G; Koga, K; Makabe, T; Miyashita, M; Osuga, Y | 1 |
| Arata, K; Enatsu, A; Harada, T; Ota, I; Taniguchi, F; Toda, T | 1 |
| Alessandri, F; Bogliolo, S; Ferrero, S; Gardella, B; Grillo, F; Leone Roberti Maggiore, U; Mastracci, L; Tafi, E; Vellone, VG | 1 |
| Fujii, T; Harada, M; Hirata, T; Hirota, Y; Izumi, G; Koga, K; Makabe, T; Miyashita, M; Osuga, Y; Sue, F; Taguchi, A; Takamura, M; Takeuchi, A; Urata, Y; Wada-Hiraike, O | 1 |
| Del Forno, S; Ferrini, G; Frascà, C; Mabrouk, M; Montanari, G; Paradisi, R; Seracchioli, R; Solfrini, S | 1 |
1 review(s) available for drospirenone and Endometrioma
| Article | Year |
|---|---|
Advances in pharmacotherapy for treating endometriosis.
Topics: Androstenes; Anti-Inflammatory Agents, Non-Steroidal; Aromatase Inhibitors; Contraceptives, Oral, Combined; Endometriosis; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Progestins | 2015 |
5 other study(ies) available for drospirenone and Endometrioma
| Article | Year |
|---|---|
Quality of Life in Japanese Patients with Dysmenorrhea or Endometriosis-Associated Pelvic Pain Treated with Extended Regimen Ethinylestradiol/Drospirenone in a Real-World Setting: A Prospective Observational Study.
Topics: Adult; Androstenes; Dysmenorrhea; Endometriosis; Female; Humans; Japan; Pelvic Pain; Quality of Life | 2022 |
Drospirenone induces decidualization in human eutopic endometrial stromal cells and reduces DNA synthesis of human endometriotic stromal cells.
Topics: Adult; Androstenes; Apoptosis; Cell Proliferation; Cells, Cultured; Decidua; DNA Replication; Dose-Response Relationship, Drug; Endometriosis; Endometrium; Female; Humans; Middle Aged; Stromal Cells | 2015 |
Effects of low dose oral contraceptive pill containing drospirenone/ethinylestradiol in patients with endometrioma.
Topics: Adult; Androstenes; Biomarkers; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dysmenorrhea; Endometriosis; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Middle Aged; Organ Size; Ovarian Diseases; Ovarian Reserve; Ovary; Pain Measurement; Progesterone Congeners; Ultrasonography; Young Adult | 2015 |
Drospirenone reduces inflammatory cytokines, vascular endothelial growth factor (VEGF) and nerve growth factor (NGF) expression in human endometriotic stromal cells.
Topics: Adult; Androstenes; Anti-Inflammatory Agents; Cells, Cultured; Contraceptives, Oral; Cytokines; Endometriosis; Endometrium; Ethinyl Estradiol; Female; Humans; Nerve Growth Factor; Receptors, Mineralocorticoid; Receptors, Progesterone; RNA, Small Interfering; Stromal Cells; Vascular Endothelial Growth Factor A | 2017 |
A new oral contraceptive regimen for endometriosis management: preliminary experience with 24/4-day drospirenone/ethinylestradiol 3 mg/20 mcg.
Topics: Adult; Androstenes; Combined Modality Therapy; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Administration Schedule; Endometriosis; Ethinyl Estradiol; Female; Follow-Up Studies; Gynecologic Surgical Procedures; Humans; Ovarian Diseases; Pilot Projects; Postoperative Period; Retrospective Studies; Treatment Outcome | 2012 |